• 제목/요약/키워드: Warfarin

검색결과 135건 처리시간 0.027초

리팜핀이 와파린의 항응고 효과에 미치는 영향 (Interaction of Rifampin and Warfarin)

  • 오연목
    • Tuberculosis and Respiratory Diseases
    • /
    • 제47권6호
    • /
    • pp.768-774
    • /
    • 1999
  • 연구배경: 리팜핀(rifampin)은 간의 시토크폼 P-450 효소를 유도하여 이 효소에 의해서 대사되는 와파린(warfarin)의 항응고 효과를 감소시킨다. 이와 같은 리팜핀과 와파린의 약제 상호작용에 대해서 건강한 지원자가 아닌 환자를 대상으로 아래의 문제를 해결하고자 본 연구를 수행하였다. 첫째 와파린을 투여하는 환자에게 리팜핀을 추가할 경우 리팜핀 투여 전, 중, 후에 항응고 효과를 적절히 유지하기 위한 와파린 용량, 둘째 리팜핀 추가 후 적절한 와파린 증량 방법(시간 계획), 셋째 와파린과 리팜핀을 함께 투여하는 경우 합병증등을 살펴 보았다. 방 법: 1995년 1월부터 1999년 8월까지 부천 세종병원에 입원한 환자 중 와파린과 리팜핀을 동시에 투여한 환자를 찾아서 질병 기록을 후향적으로 확인하였다. 리팜핀 투여 전, 중, 후의 와파린 필요량을 '적절한 항응고' 상태를 유지한 환자를 대상으로 조사하였다. 그리고, 리팜핀 추가 시 와파린 증량 방법(시간 계획)을 리팜핀 투여 후 prothrombin time 이 INR 1.1이하로 떨어지는데 걸리는 시간을 측정하여 간접적으로 평가하였다. 마지막으로 리팜핀과 와파린 동시 투여시 합병증을 조사하였다. 결 과: 라팜핀과 와파린을 동시에 투여한 환자는 모두 12명이었고 이 중 리팜핀 투여 기간 중에 '적절한 항응고' 상태를 유지한 환자는 6명이었다. 이 6명환자의 와파린 용량은 리팜핀 투여 중에 증가하여(p<0.05) 리팜핀 투여 전과 비교하여 $2.4{\pm}0.6$(평균${\pm}$표준편차) 배이었다. 그라고, 리팜핀을 중지한 후의 와파린 용량은 다시 감소하여 거의 리팜핀 사용 전의 용량으로 돌아갔다. 리팜핀 투여 후 prothrombin time이 INR 1.1이하로 떨어지는데 걸리는 시간은 $5.8{\pm}2.9$ (평균$\pm$표준편차) 일이었다. 2명이 리팜핀과 와파린 동시 투약과 관련되어 합병증이 발생하였다. 한 명은 낮은 항응고 상태 때문에 뇌색전증이 발생하였고, 다른 한명은 높은 항응고 상태 때문에 뇌출혈이 발생하여 사망하였다. 결 론: 와파린과 리팜핀을 동시에 투약하는 경우, 적절한 항응고 효과를 유지하기 위해서 리팜핀 추가 시 와파린을 약 1주에 걸쳐서 단계적으로 약 2배 증량하고 리팜핀 중단 시 리팜핀 투여 전의 와파린 용량으로 감량하는 방법을 시도해 불 수 있겠고, 이를 향후 전향적 연구를 통해서 확인하는 것이 필요하다. 또한, 리팜핀을 추가하거나 중단할 때 합병증이 발생하지 않도록 항응고 상태를 자주 감시하는 것이 필요하리라 생각된다.

  • PDF

Warfarin 및 Digoxin 정제의 처방 용량 실태 및 조제 양식의 고찰 (Study on the Prescribed Doses and Dispensing Patterns of Warfarin and Digoxin Tablets)

  • 김윤숙;이승미;천부순
    • 약학회지
    • /
    • 제58권1호
    • /
    • pp.40-46
    • /
    • 2014
  • Drugs with a narrow therapeutic index (NTI) require very precise dosing. Warfarin and digoxin are the examples of NTI-drugs and dosing of them varies widely for different patients. However, in South Korea, only two strengths of warfarin and one of digoxin are commercially available. This is a big barrier for the precise dispensing and has potential safety risks to patients, particularly to elderly patients. To find a potential solution to the problem, an analysis of the prescribed doses and dispensing patterns of those drugs was performed. Data were collected by computer-facilitated prescription review in a university hospital. The period screened was from May 1st, 2012 to April 30th, 2013. All the prescriptions with either warfarin or digoxin tablets were selected for this study and dispensing patterns were analyzed according to the prescribed doses. A total of 17,017 warfarin prescriptions were analyzed; 8,148 for inpatient prescriptions, 8,869 for outpatient prescriptions, respectively. Of the 23 kinds of prescribed doses, 2 mg (19.9%) was most frequent, followed by 3 mg (13.2%) and 2.5 mg (11.7%). By analyzing the dispensing patterns, 60.3% (10,253) of the prescriptions required pill splitting and 72.0% of them were for the patients 65 years old and over. On the other hand, 4,350 digoxin prescriptions were included in this study. Of the 6 kinds of prescribed doses, 0.125 mg (71.2%) was most frequent, followed by 0.0625 mg (20.2%). Among the prescriptions for digoxin, 92.0% (3,998) should be split and 65.7% of them were for the patients aged 65 years and over. Despite limitations of strengths, various doses of warfarin and digoxin were prescribed. Furthermore, more than half of the prescriptions that required pill splitting were for elderly patients. The results from this study suggest that different strengths of warfarin and digoxin should be provided for accuracy of dispensing and safety for patients receiving them.

Warfarin, Dansylsarcosine의 알부민결합에 미치는 유리지방산의 영향 (Influences of Free Fatty Acid on the Albumin Binding of Warfarin and Dansylsarcosine)

  • 배진우
    • 대한약리학회지
    • /
    • 제30권2호
    • /
    • pp.255-260
    • /
    • 1994
  • There are some reports about the influences of free fatty acids on the albumin binding of drugs. But they were concerned to the limited free fatty acids, mostly of azapropazone-warfarin bidning site bound drugs and determination of dissociation and association constants by stopped flow technique. These data were not enough to make conculsions for the general tendency of free fatty acid to albumin binding. Therefore the influence of various saturated fatty acids of $C_{10{\sim}20}$, oleic acid and linoleic acid as unsaturated fatty acids to albumin binding of warfarin and dansylsarcosine were studied by equilibrium dialysis. The concentration of free drug was determined by spectrophotometer according to the molar ratios of 0, 0.5, 1, 2 and 4 between free fatty acid and albumin. There were significant increasing in the free durg concentration of warfarin and dansylsarcosine when the molar ratio for capric acid, lauric acid and palmitic acid was 4. The free warfarin concentration was increased significantly at a molar ratio of 4 between oleic acid and albumin. Therefore the albumin binding of durgs can be variated significantly by increased free fatty acid of diabetics and cause to the pharmacokinetic variation between healthy and diabetics.

  • PDF

송아지에 warfarin 투여 시에 혈액 생화학치의 변화 (The Changes of Blood Biochemical Values during Warfarin Therapy in Calves)

  • 임건태;윤영민;이경갑
    • 한국임상수의학회지
    • /
    • 제20권1호
    • /
    • pp.74-78
    • /
    • 2003
  • We executed this experiment to observe side effects of warfarin, the anticoagulant that is used for preventing thrombus in cardiovascular surgery for calves. The 6 calves(70-130 kg) were used in this experiment regardless of sexes. We administered warfarin at 0.07 mg/kg daily for 25 days. Blood was collected before warfarin administration, every five days for 30 days. PCV, RBC, WBC, fibrinogen, total protein and platelet as blood test, prothrombin time (PT) as blood coagulation test, and AST, SDH, total bilirubin, BUN and creatinine as serum biochemical tests were measured. As the result of the experiment, PT has been gradually increased after warfarin administration. It has been gradually increased and remains within the therapeutic range from the third day to the 28th day. PCV and RBC were decreased significantly from the value before the administration (p < 0.05). In the serum biochemical test, SDH shows significant increase comparing the value before the administration (p < 0.05). AST and total bilirubin were increased gradually from the value before the administration. Considering the result of the experiment, to give wafarin to prevent thrombus in cardiovascular surgery, we can get anticoagulation effect with minimal administration(0.07 mg/kg, PO) from the third day of the administration. However because of the decreased PCV and RBC, it may cause anemia. It may cause damage to liver based on the result of serum biochemical test.

뇌졸중 환자군의 Warfarin Nomogram 설정을 위한 실제 처방전 평가 (Evaluation of Prescription Data for Development of Warfarin Nomogram in Korean Patients with Cerebral Infarction)

  • 장주영;고경미;윤지연;한옥연;임성실
    • 약학회지
    • /
    • 제53권2호
    • /
    • pp.83-88
    • /
    • 2009
  • Warfarin is the most widely used oral anticoagulant in the world but maintenance of proper therapeutic range and prevention of adverse drug events always need to be careful. Especially, in Korea, warfarin dosing for patients with cerebral infarction is currently based on the nomogram which is done by foreign clinical trials not for the Korean. Therefore we evaluate warfarin dose of patients in the neurology and eventually get the base data of warfarin nomogram for Korean with stroke. We performed this study retrospectively on reviewing the medical charts to evaluate the prescribed loading dose (LD) and maintenance dose (MD) of warfarin and each responding International Normalized Ratio (INR) with any bleeding adverse drug reaction including of patient's characteristics for total 75 patients with stroke in the department of neurology of Kangnam ST. Mary's Hospital from January 2005 to June 2008. All evaluated patients should not be treated with warfarin in the past at all and should be initiated warfarin therapy first.ly at this time. All evaluated patients were divided as two classes by wafarin LD which is; 1) HDG - a high loading dosing group prescribed over 5mg, and 2) LDG - a low loading dosing group prescribed 5mg or below. As a result, average LD was $9.34{\pm}0.22$ mg (p=0.000) in HDG and $4.25{\pm}0.39$ mg (p=0.000) in LDG. Average baseline INR was $0.91{\pm}0.05$ (p=0.161) in HDG and $1.26{\pm}0.14$ (p=0.002) in LDG. On the first and second week, daily MD was $4.21{\pm}0.14$ mg (p=0.000) and $2.96{\pm}0.19$ mg (p=0.696) in HDG and also in LDG, $2.95{\pm}0.29$ mg (p=0.000) and $3.14{\pm}0.36$ mg (p=0.696). Also average reacting daily INR was respectively $2.53{\pm}0.12$ (p=0.141) and $2.51{\pm}0.16$ (p=0.678) in HDG, and in LDG, $2.11{\pm}0.17$ (p=0.141) and $2.42{\pm}0.14$ (p=0.678). After the second week, INR was not measured in regularly. Also most of underlying diseases were hypertension (n=38), diabetes mellitus (n=14), dyslipidemia (n=8) in order. Four ADRs with simple hemorrhage were occurred and those were due to drug interaction by comedication. In the conclusion, proper starting LD for Korean with stroke is 10 mg if baseline INR is around 1.0 or 5 mg if over 1.3. Proper MD need to be more evaluated in the future for setting up warfarin nomogram to make prospective study.

뇌경색 입원환자대상으로 한약과 Warfarin 의 복합 투여시 미치는 Prothrombin Time (INR) 의 변화에 대한 후향적 단면연구 (A Retrospective Sectional Study about the Effect of the Interaction of Herbal Medicines and Warfarin on Prothrombin Time(INR) in Stroke Patients)

  • 이상헌;김영석;강철호;송문구;두호경;안세영;안영민;이병철
    • 대한한방내과학회지
    • /
    • 제28권3호
    • /
    • pp.464-472
    • /
    • 2007
  • Objectives : Nowadays the combined use of oriental herbal medicines and western biomedical medicines has been prevalent but controversial. Warfarin has been much reported to interact with some herbal medicines so that it influences prothrombin time(PT) & international normalized ratio(INR). This study was aimed to examine how much warfarin interacts with herbal medicines during treatment of stroke patients Methods : This was a retrospective case control study of 53 patients whowere treated with concomitant treatment of herbal medicines & warfarin. They were within normal limit in liver function, renal function, hematocrit, hemoglobin, and platelet count at first admission lab. We classified them into 2 classes: study group (taking herbal medicines including Panax ginseng, Angelica sinensis, Zingiber officinale, Salvia miltiorrhiza that were reported to interact with warfarin to impact PT (INR) and control group (taking other herbal medicines). We followed up PT (INR) at 5-10 days interval with AST, ALT, BUN, creatinine, hematocrit, hemoglobin, and platelet count. Results : AST, BUN, creatinine, hemoglobin, hematocrit, and platelet count were not changed significantly between first and final tests during the admission period. Only ALT decreased significantly in the control group. Neither baseline nor peak PT (INR) was significantly different between the groups. However, only warfarin dose was significantly correlated with PT and INR (r=0.810, r=0.798, p<0.01). Conclusions : It was concluded that PT(INR) was not influenced with herbal medicines and warfarin but by far dependent on warfarin dose in stroke patients restricted with normal liver function, renal function, and hematocrit, hemoglobin, and platelet count. Further prospective study is needed on larger samples to conclude that the combined therapy of herbal medicines and warfarin is safe.

  • PDF

A Korean Multi-Center Survey about Warfarin Management before Gastroenterological Endoscopy in Patients with a History of Mechanical Valve Replacement Surgery

  • Son, Kuk Hui;Choi, Chang-Hyu;Lee, Jae-Ik;Kim, Kun Woo;Kim, Ji Sung;Lee, So Young;Park, Kook Yang;Park, Chul Hyun
    • Journal of Chest Surgery
    • /
    • 제49권5호
    • /
    • pp.329-336
    • /
    • 2016
  • Background: Guidelines for esophagogastroduodenoscopy (EGD) in the West allow the continued use of warfarin under therapeutic international normalized ratio (INR) level. In Korea, no guidelines have been issued regarding warfarin treatment before EGD. The authors surveyed Korean cardiac surgeons about how Korean cardiac surgeons handle warfarin therapy before EGD using a questionnaire. Participants were requested to make decisions regarding the continuation of warfarin therapy in two hypothetical cases. Methods: The questionnaire was administered to cardiac surgeons and consisted of eight questions, including two case scenarios. Results: Thirty- six cardiac surgeons at 28 hospitals participated in the survey, and 52.7% of the participants chose to stop warfarin before EGD in aortic valve replacement patients without risk factors for thromboembolism. When the patient's INR level was 2, 31% of the participants indicated that they would choose to continue warfarin therapy. For EGD with biopsy, 72.2% of the participants chose warfarin withdrawal, and 25% of the participants chose heparin replacement. In mitral valve replacement patients, 47.2% of the participants chose to discontinue warfarin, and 22.2% of the participants chose heparin replacement. For EGD with biopsy in patients with a mitral valve replacement, 58.3% of the participants chose to stop warfarin, and 41.7% of the participants chose heparin replacement. Conclusion: This study demonstrated that attitudes regarding warfarin treatment for EGD are very different among Korean surgeons. Guidelines specific to the Korean population are required.

$^{14}C$-warfarin의 분포 및 쿠마린 유도체류에 의하여 간에서 유도된 동위효소의 정제 (The distribution of $^{14}C$-warfarin and the purification of hepatic microsome induced isozymes with coumarin)

  • 박성우;김은호;민지숙;유재훈;이희성;서배석;한완수
    • 분석과학
    • /
    • 제5권1호
    • /
    • pp.83-90
    • /
    • 1992
  • $^{14}C$-warfarin을 흰쥐에 경구투여 후 4시간 경과시 혈액에서 최고치를 나타내었으며, coumarin과 그 유도체인 warfarin에 의한 간조직 microsome 내의 Cyt. p-450은 이들 화합물에 의해 microsomal electron transport system이 증가됨과 Cyt. p-450의 isozyme들이 유도됨을 확인할 수 있었다.

  • PDF

한약과 와파린 병용의 상호작용과 안전성에 대한 연구 (Evaluation of Interaction and Safety in Administering Herb-medicine with Warfarin)

  • 권동현;김호준;이명종;송미영
    • 한방재활의학과학회지
    • /
    • 제20권2호
    • /
    • pp.175-181
    • /
    • 2010
  • Objectives : The purpose of this study is to investigate interaction and safety in administering herb-medicine with warfarin. Methods : For this study, we selected 19 patients who have been taking warfarin, from the ones that have been transferred from western hospital to oriental hospital. During their stay in the oriental hospital, we gave herb-medicine in addition to warfarin. Then we gathered informations and data on sex, age, main indications, and International Normalized Ratio(INR) values of selected patients through Electronic Medical Records(EMR) of Dong-Guk university hospital. Accordingly, we compiled all of the above data for a period of 10 days prior and 10 days post admission(western hospital period and oriental hospital period, respectively). Results and Conclusions : The statistical analysis of the data have revealed that there was no significant change of INR values after giving herb-medicine with warfarin(p=0.586). The result shows that administration of herb-medicine with warfarin is safe and has little drug interaction. However, this study was carried out on small sample size and the interaction with other drugs and various kinds of herb-medicine was not considered. Although we attained a restrictive result from this study, we are able to suggest the safety about co-administration of herb-medicine and warfarin.

와파린의 HPLC 분석법 및 한국인에서의 약동학적 특징 (HPLC Determination and Pharmacokinetic Profile of Warfarin in Korean Subjects)

  • 배정우;김현경;양상인;김지홍;김경혜;장춘곤;박영서;손의동;이석용
    • 약학회지
    • /
    • 제49권2호
    • /
    • pp.134-139
    • /
    • 2005
  • Warfarin is a widely used oral anticoagulant agent used to treat thromboembolic disease. The purpose of this study was to develop the efficient assay method of warfarin sodium i n human plasma and to assess the pharmacokinetic profile of the warfarin in healthy Korean volunteers. The pharmacokinetics of warfarin administered orally was evaluated after a dose of 10 mg. Warfarin in plasma was assayed using a specific HPLC method with UV absorbance at 304 nm. AUC was 46.33${\pm}9.95{\mu}g/ml.hr$, $C_{max}$ $1.22{\pm}0.22{\mu}g/ml, $T_{max}$$2.50{\pm}1.41$ hr and half-life $43.49{\pm}4.33$ hr. $T_{max}$ was slightly shorter than that in Caucasian (3~9 hr), whereas the half-life was longer than that in Caucasian (10~45 hr, mean: 36 hr). These results suggest that warfarin may have a longer duration in Korean than in Caucasian.